Mark W. Stahlhut

3.2k citations

45 papers · 1.7k indexed · h-index 21

Hepatology top 2%
- Hepatitis C virus research 17
Virology top 2%
- HIV Research and Treatment 18
Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 31
Hematology top 5%
- Iron Metabolism and Disorders 6
Genetics top 10%
Molecular Biology
- Biochemical and Molecular Research 10
- RNA modifications and cancer 6
Epidemiology
- Hepatitis B Virus Studies 6
Organic Chemistry
- Click Chemistry and Applications 4

Co-authors: David B. Olsen Hie‐Won Hann Steven S. Carroll H W Hann Lawrence C. Kuo B. S. Blumberg Carrie A. Rutkowski Malcolm MacCoss
Cited by: Hepatology Virology Infectious Diseases
Journals: Journal of the American Chemical Society (1 paper)Journal of Biological Chemistry (4 papers)Angewandte Chemie International Edition (1 paper)
Partner nations: United States Italy Canada

In The Last Decade

Mark W. Stahlhut

45 papers receiving 1.6k citations

Peers

Countries citing papers authored by Mark W. Stahlhut

Since Specialization

Citations

This map shows the geographic impact of Mark W. Stahlhut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Stahlhut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Stahlhut more than expected).

Fields of papers citing papers by Mark W. Stahlhut

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Stahlhut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Stahlhut. The network helps show where Mark W. Stahlhut may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark W. Stahlhut, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark W. Stahlhut Line = papers co-authored together Mark W. Stahlhut links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A transient cell-based phenotype assay for hepatitis C NS3/4A protease: Application to potency determinations of a novel macrocyclic inhibitor against diverse protease sequences isolated from plasma infected with HCV Journal of Virological Methods ·Steven W. Ludmerer,Donald J. Graham,Mihir Patel,Kevin F. Gilbert,Mark W. Stahlhut,David B. Olsen	2008	13
2	Bismacrocyclic Inhibitors of Hepatitis C NS3/4a Protease Angewandte Chemie International Edition ·John A. McCauley,Michael T. Rudd,Kevin T. Nguyen,Charles McIntyre,Joseph J. Romano,Kimberly J. Bush,Sándor Varga,Charles W. Ross,Steven S. Carroll,Jillian DiMuzio,Mark W. Stahlhut,David B. Olsen,Terry A. Lyle,Joseph P. Vacca,Nigel J. Liverton	2008	18
3	Synthesis and HCV inhibitory properties of 9-deaza- and 7,9-dideaza-7-oxa-2′-C-methyladenosine Bioorganic & Medicinal Chemistry ·Gabor Butora,David B. Olsen,Steven S. Carroll,Daniel R. McMasters,Christoph Schmitt,Joseph F. Leone,Mark W. Stahlhut,Christine Burlein,Malcolm MacCoss	2007	24
4	Synthesis of novel HIV protease inhibitors (PI) with activity against PI-resistant virus Bioorganic & Medicinal Chemistry Letters ·Subharekha Raghavan,Zhijian Lu,Teresa Beeson,Kevin T. Chapman,William A. Schleif,David B. Olsen,Mark W. Stahlhut,Carrie A. Rutkowski,Lori J. Gabryelski,Emilio A. Emini,James R. Tata	2007	8
5	Design, synthesis, and biological evaluation of monopyrrolinone-based HIV-1 protease inhibitors possessing augmented P2′ side chains Bioorganic & Medicinal Chemistry Letters ·Amos B. Smith,Adam K. Charnley,Hironori Harada,Jason J. Beiger,Louis‐David Cantin,Craig S. Kenesky,Ralph Hirschmann,Sanjeev Munshi,David B. Olsen,Mark W. Stahlhut,William A. Schleif,Lawrence C. Kuo	2005	18
6	A genotype 2b NS5B polymerase with novel substitutions supports replication of a chimeric HCV 1b:2b replicon containing a genotype 1b NS3-5A background Antiviral Research ·Donald J. Graham,Mark W. Stahlhut,Osvaldo Flores,David B. Olsen,Daria J. Hazuda,Robert L. LaFemina,Steven W. Ludmerer	2005	13
7	P1′ oxadiazole protease inhibitors with excellent activity against native and protease inhibitor-resistant HIV-1 Bioorganic & Medicinal Chemistry Letters ·Ronald M. Kim,Elizabeth A. Rouse,Kevin T. Chapman,William A. Schleif,David B. Olsen,Mark W. Stahlhut,Carrie A. Rutkowski,Emilio A. Emini,James R. Tata	2004	21
8	Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease Biochemical and Biophysical Research Communications ·Sheo B. Singh,John G. Ondeyka,Nasios Tsipouras,Carolyn L. Ruby,Vinod Sardana,Marvin Schulman,Manuel Almagro Sánchez,Fernando Peláez,Mark W. Stahlhut,Sanjeev Munshi,David B. Olsen,Russell B. Lingham	2004	33
9	HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1′ substituent Bioorganic & Medicinal Chemistry Letters ·Joseph Duffy,Brian A. Kirk,Nancy J. Kevin,Kevin T. Chapman,William A. Schleif,David B. Olsen,Mark W. Stahlhut,Carrie A. Rutkowski,Lawrence C. Kuo,Lixia Jin,Jiunn H. Lin,Emilio A. Emini,James R. Tata	2003	10
10	Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs Journal of Biological Chemistry ·Steven S. Carroll,Joanne E. Tomassini,Michele Bosserman,Krista Getty,Mark W. Stahlhut,Anne B. Eldrup,Balkrishen Bhat,Dawn L. Hall,Amy L. Simcoe,Robert L. LaFemina,Carrie A. Rutkowski,B. Wolanski,Zhucheng Yang,Giovanni Migliaccio,Raffaele De Francesco,Lawrence C. Kuo,Malcolm MacCoss,David B. Olsen	2003	281
11	Design and synthesis of highly potent HIV protease inhibitors with activity against resistant virus Bioorganic & Medicinal Chemistry Letters ·Zhijian Lu,Subharekha Raghavan,Joann Bohn,Mark G. Charest,Mark W. Stahlhut,Carrie A. Rutkowski,Amy L. Simcoe,David B. Olsen,William A. Schleif,Anthony Carella,Lori J. Gabryelski,Lixia Jin,Jiunn H. Lin,Emilio A. Emini,Kevin T. Chapman,James R. Tata	2003	12
12	Combinatorial library of indinavir analogues: replacement for the aminoindanol at P2′ Bioorganic & Medicinal Chemistry Letters ·Subharekha Raghavan,Zheng Rong Yang,Ralph T. Mosley,William A. Schleif,Lori J. Gabryelski,David B. Olsen,Mark W. Stahlhut,Lawrence C. Kuo,Emilio A. Emini,Kevin T. Chapman,James R. Tata	2002	6
13	Indinavir analogues with blocked metabolism sites as HIV protease inhibitors with improved pharmacological profiles and high potency against PI-Resistant viral strains Bioorganic & Medicinal Chemistry Letters ·Yuan Cheng,Fengqi Zhang,Thomas A. Rano,Zhijian Lu,William A. Schleif,Lori J. Gabryelski,David B. Olsen,Mark W. Stahlhut,Carrie A. Rutkowski,Jiunn H. Lin,Lixia Jin,Emilio A. Emini,Kevin T. Chapman,James R. Tata	2002	23
14	A Combinatorial Library of Indinavir Analogues and Its In Vitro and In Vivo Studies Bioorganic & Medicinal Chemistry Letters ·Yuan Cheng,Thomas A. Rano,Tracy T Huening,Fengqi Zhang,Zhijian Lu,William A. Schleif,Lori J. Gabryelski,David B. Olsen,Mark W. Stahlhut,Lawrence C. Kuo,Jiunn H. Lin,Xin Xu,Lixia Jin,Timothy Olah,Debra A. McLoughlin,Rick C King,Kevin T. Chapman,James R. Tata	2002	6
15	Elucidation of Basic Mechanistic and Kinetic Properties of Influenza Endonuclease Using Chemically Synthesized RNAs Journal of Biological Chemistry ·David B. Olsen,Fritz Benseler,James L. Cole,Mark W. Stahlhut,Robert E. Dempski,Paul L. Darke,Lawrence C. Kuo	1996	20
16	[8] Expression and purification of retroviral HIV-1 reverse transcriptase Methods in enzymology on CD-ROM/Methods in enzymology ·Mark W. Stahlhut,David B. Olsen	1996	10
17	Sensitivity of HIV-1 Reverse Transcriptase and Its Mutants to Inhibition by Azidothymidine Triphosphate Biochemistry ·Steven S. Carroll,James Geib,David B. Olsen,Mark W. Stahlhut,Jules A. Shafer,Lawrence C. Kuo	1994	51
18	Purification and Characterization of HIV-1 Reverse Transcriptase Having a 1:1 Ratio of p66 and p51 Subunits Protein Expression and Purification ·Mark W. Stahlhut,Yu Li,Jon H. Condra,Jing-Li Fu,L Gotlib,Donald J. Graham,David B. Olsen	1994	9
19	Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice Cancer ·Hie‐Won Hann,Mark W. Stahlhut,Raphael Rubin,Willis C. Maddrey	1992	85
20	Iron enhances tumor growth. Observation on spontaneous mammary tumors in mice Cancer ·Hie‐Won Hann,Mark W. Stahlhut,Hyman Menduke	1991	61

About Mark W. Stahlhut

Mark W. Stahlhut is a scholar working on Virology, Hepatology and Infectious Diseases, having authored 45 papers that have together received 1.7k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (31 papers), HIV Research and Treatment (18 papers), Hepatitis C virus research (17 papers), Biochemical and Molecular Research (10 papers), Iron Metabolism and Disorders (6 papers), RNA modifications and cancer (6 papers), Hepatitis B Virus Studies (6 papers) and Click Chemistry and Applications (4 papers). The work is most often cited by research in Hepatology (472 citations), Virology (252 citations) and Infectious Diseases (656 citations). Mark W. Stahlhut has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include David B. Olsen, Hie‐Won Hann, Steven S. Carroll, H W Hann, Lawrence C. Kuo, B. S. Blumberg, Carrie A. Rutkowski, Malcolm MacCoss, Christine L. Hann and Joanne E. Tomassini. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact